微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -8.24% | -186.11% | 81.9% | 140/158 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -45.52% | 10.23% | -210.08% | 143/158 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -14.68% | 37.74% | -51.81% | 141/158 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -9.67% | 45.52% | -235.76% | 141/158 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -2.88% | 59.21% | 94.32% | 133/158 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -50.71% | -279.85% | -115.06% | 143/158 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -23.58% | -232.11% | -32.85% | 144/158 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -17.75% | -516.32% | -151.42% | 145/158 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -7.06% | -702.27% | 47.12% | 139/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -13.35% | -130.97% | -88.03% | 129/158 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -7.1% | -153.57% | -146.53% | 125/158 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -2.88% | 30.6% | -227.27% | 128/158 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -0.88% | -383.87% | 84.78% | 122/158 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -5.78% | -2323.08% | -106.43% | 123/158 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | -2.8% | -206.87% | 32.53% | 119/158 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -4.15% | -780.33% | -1438.71% | 131/158 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.31% | -3.13% | 19.23% | 107/158 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 0.26% | 138.81% | -90.08% | 109/158 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 2.62% | 4.8% | 329.51% | 87/158 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.61% | 510% | 90.63% | 103/158 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.32% | -76.64% | 147.76% | 82/158 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -0.67% | -140.85% | -126.8% | 117/158 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 2.5% | 127.27% | 2400% | 93/158 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.1% | -86.11% | -92.7% | 106/158 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.37% | -36.87% | -16.46% | 72/158 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 1.64% | -70.66% | 49.09% | 112/158 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 1.1% | -79.48% | 52.78% | 96/158 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 0.72% | -84.78% | -66.82% | 97/158 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.17% | -40.22% | -61.18% | 49/158 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 5.59% | -52.71% | 4.29% | 80/158 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.36% | -51.76% | 13.32% | 62/158 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.73% | -33.19% | 30.3% | 48/158 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.63% | -31.38% | -69.29% | 15/158 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 11.82% | -53.72% | 6.39% | 43/158 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 11.11% | -50.8% | 56.92% | 21/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 7.08% | -61.14% | 33.84% | 26/158 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 5.29% | -66.02% | -79.29% | 11/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 25.54% | -54.95% | 13.11% | 15/158 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 22.58% | -48.62% | 23.93% | 5/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 18.22% | 2% | 17.02% | 2/158 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 15.57% | 2% | -72.53% | 1/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |